Amphastar Pharmaceuticals
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1996-01-01
- Employees
- 1.7K
- Market Cap
- $2.3B
- Website
- http://www.amphastar.com
- Introduction
Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments. The Finished P...
Director Petersen Floyd F. sold $139,417 worth of shares (3,000 units at $46.47), decreasing ...
Amphastar Pharmaceuticals' CFO Bill Peters and EVP Tony Marrs to participate in a fireside chat at the 2024 Wells Fargo Healthcare Conference on Sept 5, 2024, at 10:15 am EST. Webcast available for 30 days at http://ir.amphastar.com.
© Copyright 2024. All Rights Reserved by MedPath